quality-nonconformance

A non-conformance report (NCR) in regulated manufacturing is managed by guiding the lifecycle from identification to disposition and MRB using auditable workflows. This ensures traceable evidence for FDA 21 CFR 820, IATF 16949, and AS9100 compliance.

The best way to perform root-cause analysis for quality issues is using structured methods like 5 Whys, Ishikawa diagrams, and Fault Tree Analysis (FTA). These techniques diagnose nonconformances to support effective CAPA planning.

You plan and verify CAPA effectiveness for FDA 21 CFR 820 compliance by implementing corrective actions and conducting effectiveness verification checks. This maintains audit-ready records with regulatory alignment and traceable evidence throughout the process.

Yes, this approach supports supplier quality management by handling Supplier Corrective Action Requests (SCARs), Approved Supplier List (ASL) maintenance, and audit readiness. It manages supplier-related quality events alongside incoming inspections and field failures.

You need SPC interpretation and process capability assessment for non-conformances when diagnosing in-process issues and field failures. Interpreting control charts helps determine process stability and informs the root-cause analysis within the NCR lifecycle.